ASX ANNOUNCEMENT 28 October 2026 Vitrafy Life Sciences Quarterly Activities Report & Appendix 4C Quarter 1, Financial Year 2027 Melbourne, Australia: Vitrafy Life Sciences Limited (ASX: VFY) (“Vitrafy” or “the Company”), an Australian innovator in cryopreservation technology, presents its...
Q1 FY27 Quarterly Activities Report and Appendix 4C
Filed with ASX ·
6ix is reading this filing.
Vitrafy Life Sciences Ltd. on 6ix
In the deck
Story so far
Earlier from Vitrafy Life Sciences
- Vitrafy enters partnership with Versiti Blood Health
- S&P DJI Announces September 2026 Quarterly Rebalance
- Vitrafy enters U.S. Cell & Gene Therapy Market
- FY26 Full Year Results Presentation
- FY26 Appendix 4E and Annual Report
Follow Vitrafy Life Sciences into a list and get an email when it puts out news.
Follow Vitrafy Life Sciences